ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	78.34	-18.52	18.78	-47.9	-42.6
Depreciation & Amortization	91.42	67.73	59.79	59.65	47.25
Loss (Gain) From Sale of Assets	0.38	-5.35	-	-0.75	-1.82
Asset Writedown & Restructuring Costs	0.77	7.6	-	1.73	2.37
Loss (Gain) From Sale of Investments	-2.82	-6.31	-	-	-
Stock-Based Compensation	37.93	29.34	20.65	14.6	10.49
Other Operating Activities	-13.66	0.7	-5.12	-7.23	-12.28
Change in Accounts Receivable	-58.53	-21.09	3.36	-36.91	-5.55
Change in Inventory	-5.96	-21.29	-5.84	-23.63	3.22
Change in Accounts Payable	15.16	0.48	7.55	5.04	10.17
Change in Income Taxes	-15.53	-1.42	11.99	-0.16	-7.57
Change in Other Net Operating Assets	57.74	32.13	7.8	4.36	-0.35
Operating Cash Flow	185.23	64.02	118.96	-31.2	3.32
Operating Cash Flow Growth	189.34%	-46.19%	-	-	-78.24%
Capital Expenditures	-13.84	-16.24	-8.87	-8.88	-2.56
Sale of Property, Plant & Equipment	-	13.51	-	0.75	2.65
Cash Acquisitions	-	-401.28	-	-0.03	-84.49
Sale (Purchase) of Intangibles	-20.49	-0.72	-9.64	-7.58	-21.08
Investing Cash Flow	-34.32	-404.72	-18.51	-15.74	-105.48
Long-Term Debt Issued	-	641.25	-	-	310.03
Long-Term Debt Repaid	-10.16	-296.03	-3	-3	-211.01
Total Debt Repaid	-10.16	-296.03	-3	-3	-211.01
Net Debt Issued (Repaid)	-10.16	345.22	-3	-3	99.02
Issuance of Common Stock	13.6	6.49	89.55	1.46	71.65
Repurchase of Common Stock	-12.21	-10.96	-4.99	-1.96	-0.89
Preferred Dividends Paid	-1.16	-1.63	-1.63	-1.63	-0.19
Dividends Paid	-1.16	-1.63	-1.63	-1.63	-0.19
Other Financing Activities	-0.03	-74.18	-12.5	-	-
Financing Cash Flow	-9.94	264.95	67.44	-5.13	194.6
Foreign Exchange Rate Adjustments	-0.23	-0.47	-	-	-
Net Cash Flow	140.73	-76.23	167.89	-52.07	92.43
Free Cash Flow	171.39	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	258.70%	-56.60%	-	-	-91.62%
Free Cash Flow Margin	19.40%	7.78%	22.61%	-12.67%	0.35%
Free Cash Flow Per Share	8.07	2.47	6.05	-2.46	0.06
Cash Interest Paid	-	24.38	31.43	21.48	9.71
Cash Income Tax Paid	-	19.06	1.23	0.29	10.37
Levered Free Cash Flow	91.82	28.57	114.36	-38.7	-28.62
Unlevered Free Cash Flow	104.35	49.28	136.26	-20.94	-21.16
Change in Working Capital	-7.12	-11.19	24.86	-51.3	-0.08

Updated Feb 27, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q